Small Caps Charge, Big Caps Pause; GE Vernova, Genmab, Eli Lilly In Focus
Stock Market Today With IBD
00:00
Eli Lilly tests 21-day line
Alexis and Ed examine LLY's pullback to the 21-day line, volume profile and implications of FDA trial news.
Play episode from 13:06
Transcript
